These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9213524)

  • 1. [An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
    Stara J; Krásný J; Plísková S; Síblová O
    Cesk Slov Oftalmol; 1997 Feb; 53(1):46-8. PubMed ID: 9213524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
    Kremer B; Tündermann A; Goldschmidt O
    Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antazoline/tetryzoline eyedrops in comparison with levocabastine eyedrops in acute allergic conjunctivitis].
    Wertheimer R; Blessmann G
    Klin Monbl Augenheilkd; 1997 Feb; 210(2):93-6. PubMed ID: 9229602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter evaluation of a new local antihistaminic drug (levocabastine)].
    Bischoff P; Gerber M
    Klin Monbl Augenheilkd; 1992 May; 200(5):354-7. PubMed ID: 1351957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic levocabastine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):35-6. PubMed ID: 7908401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allergodil eye drops in the treatment of allergic conjunctivitis].
    Haicl P; Cerná H
    Cesk Slov Oftalmol; 2002 Jul; 58(4):254-8. PubMed ID: 12181881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
    Graue E
    Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
    Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
    Endre L
    Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levocabastine--a new antihistaminic for local treatment].
    Larsen BB; Pedersen B; Dahl R
    Ugeskr Laeger; 1993 Jun; 155(26):2070-3. PubMed ID: 8101023
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
    Fujishima H; Fukagawa K; Tanaka M; Uchio E; Takamura E; Nakagawa Y; Miyazaki D; Fukushima A; Okamoto S; Yokoi N
    Ophthalmologica; 2008; 222(4):232-9. PubMed ID: 18463425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olopatadine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):108-9. PubMed ID: 9398823
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
    Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The curative effect of livostin spray on treating allergic rhinitis of children].
    Wang S; Xu Z; Xu R; Wang Z; Rao K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 15(4):171-2. PubMed ID: 12541644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
    Kamis U; Ozturk BT; Ozkagnici A; Gunduz K
    Acta Ophthalmol Scand; 2006 Feb; 84(1):148-9. PubMed ID: 16445458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.